Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04894006 · ClinicalTrials.gov registry record · NA
Dementia Family Caregiver Study
A NA study of Dementia Caregiver, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 1
- Study location
NCT04894006: Recruiting NA study of Dementia Caregiver, sponsored by University of California, Irvine.
NCT04894006 is a NA study of Dementia Caregiver that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 332 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04894006, a NA study of Dementia Caregiver, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study will test a 3-month, community health worker (CHW) delivered home visit, culturally and language-appropriate intervention for ethnic and underserved dementia family caregivers of persons with dementia (PWD) using wearable technology for real time monitoring of caregivers' stress and sleep. The CHW delivered home visit intervention includes stress reduction techniques by mindful deep breathing and compassionate support/listening and caregiving education to improve caregiver's health, wellbeing, and positive interactions with the PWD. This dementia caregiver study using wearable technology has the potential to significantly lessen health disparities in dementia care, assisting underserved ethnic dementia caregivers in self-management and increasing their quality of life.
Primary Outcome
The Zarit Burden Interview will be used to evaluate dementia informal caregiver burden three times throughout the study to assess changes in caregiver burden.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Community Health Worker (CHW) Home Visit Intervention
- BEHAVIORAL Attention Control Group with WIoT Technology
Study Locations (1)
California
- University of California, Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2021-05-19 |
| Est. Completion | 2026-05-30 |
| Phase | NA |
What NCT04894006 shows while recruiting
NCT04894006 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Dementia Caregiver appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT04894006 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04894006 about?
NCT04894006 is a clinical study titled "Dementia Family Caregiver Study". The proposed study will test a 3-month, community health worker (CHW) delivered home visit, culturally and language-appropriate intervention for ethnic and underserved dementia family caregivers of persons with dementia (PWD) using wearable technology for real time monitoring of caregivers' stress a...
What is the current status of trial NCT04894006?
This trial is currently recruiting. It is a NA study. The enrollment target is 332 participants. The study started on 2021-05-19. Estimated completion is 2026-05-30.
What conditions does trial NCT04894006 study?
This clinical trial studies the following conditions: Dementia Caregiver.
What interventions are being tested in trial NCT04894006?
The interventions under investigation include: Usual Care (BEHAVIORAL), Community Health Worker (CHW) Home Visit Intervention (BEHAVIORAL), Attention Control Group with WIoT Technology (BEHAVIORAL).
Who is sponsoring clinical trial NCT04894006?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04894006 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia Caregiver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04894006's enrollment target sits among peer trials
332 306th of 2000 higher than 1,694 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- NCT05320588 · 332 participants · Phase 1
A Study in Patients With Advanced Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI